Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans

INTRODUCTION: Providing smokers feedback using epigenetic markers of lung cancer risk has yet to be tested as a strategy to motivate smoking cessation. Epigenetic modification of Rb-p16 (p16) due to tobacco exposure is associated with increased risk of developing lung cancer. This study examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shofer, Scott, Beyea, Matthew, Li, Sufeng, Bastian, Lori A, Wahidi, Momen M, Kelley, Michael, Lipkus, Isaac M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Smoking
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212704/
https://www.ncbi.nlm.nih.gov/pubmed/25478181
http://dx.doi.org/10.1136/bmjresp-2014-000032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212704/
https://www.ncbi.nlm.nih.gov/pubmed/25478181
http://dx.doi.org/10.1136/bmjresp-2014-000032

Ejemplares similares